August 19, 2016

Winners of vital funding for lung cancer research announced at Australian Lung Cancer Conference

Lung Foundation Australia has recognised the vital need for more research into lung cancer with several awards being announced at the Australian Lung Cancer Conference Gala Dinner tonight.

The first of eight two year Deep Manchanda Lung Cancer Fellowships, each worth at least $160,000, was awarded to University of Newcastle’s Dr Atiqur Rahman for his work on elucidating and targeting genomic and epigenetic changes in the development and progression of lung cancer.

Lung Foundation Australia CEO Heather Allan said the Deep Manchanda Lung Cancer Fellowships were made possible through a significant donation by the Manchanda family to support early career lung cancer post-doctoral students.

“The University of Newcastle will co-fund the first fellowship as well as an additional PhD scholarship, taking the total value of this award to almost half a million dollars,” Mrs Allan said.

“By matching donations with support from academic partners, Lung Foundation Australia is able to extend and increase the value of the award as well as maximising the return for the community,” she said.

“We’re working closely with our partners to ensure generous gifts given by our donors are used in the best and most effective ways possible.”

Other awards announced tonight include the Lung Foundation Australia Grant in Aid in Lung Cancer Research which will be presented to the Ingham Institute for Applied Medical Research’s  Dr Pei Ding for her work identifying novel mechanisms of acquired resistance in advanced Epidermal Growth Factor Receptor mutated (EGFR+) non-small cell lung cancer (NSCLC).

Mrs Allan said the Foundation was also announcing two other new co-funded PhD scholarships with the University of Melbourne and the Walter and Eliza Hall Institute of Medical Research.

“We’ve set the ambitious goal that by 2020 we’ll be contributing $5 million a year to support research – both research awards and research platforms, including our lung cancer trials groups and our disease-based registries (IPF and Bronchiectasis),” she said.

“And this year sees us take a significant step in that direction.

For more information about the research awards and Lung Foundation Australia’s commitment to building lung health research, visit